Needham, United States
Biofourmis, founded in 2015, is a standout in the Analytics, Biotechnology, Digital Health, and Health and Wellness sectors. Renowned for its slogan, "Revolutionizing the Delivery of Healthcare," the company leverages AI-driven solutions to analyze over 120 biomarkers in real time. This technology facilitates proactive interventions, enabling access to hospital-level services, virtual provider networks, and clinical trials—all from the comfort of patients' homes. Headquartered in the United States with key offices in Singapore and India, Biofourmis has established itself as a global leader in healthcare innovation.
The company significantly improves patient outcomes, reduces hospitalization readmissions, and accelerates drug development, earning the trust of leading health systems, payers, and biopharma companies. Biofourmis most recently secured a $20.00M Series D investment from Intel Capital on July 27, 2022, underscoring its promising dedication to transforming healthcare delivery.
